Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ficolin-3 induces apoptosis and suppresses malignant property of hepatocellular carcinoma cells via the complement pathway.

Autor: Zheng G; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America; Department of Clinical Laboratory, Qilu Hospital of Shandong University, China., Wu L; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Bouamar H; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Cserhati M; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Chiu YC; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, TX, United States of America., Hinck CS; Department of Structural Biology, University of Pittsburgh School of Medicine, PA, United States of America., Wieteska Ł; Department of Structural Biology, University of Pittsburgh School of Medicine, PA, United States of America., Zeballos Torrez CR; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Hu R; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Easley A; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America., Chen Y; Department of Structural Biology, University of Pittsburgh School of Medicine, PA, United States of America; Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, TX, United States of America., Hinck AP; Department of Structural Biology, University of Pittsburgh School of Medicine, PA, United States of America., Cigarroa FG; Transplant Center, University of Texas Health Science Center at San Antonio, TX, United States of America. Electronic address: Cigarroa@uthscsa.edu., Sun LZ; Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, TX, United States of America. Electronic address: Sunl@uthscsa.edu.

Publikováno v: Life sciences [Life Sci] 2024 Nov 15; Vol. 357, pp. 123103. Date of Electronic Publication: 2024 Sep 30.

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.

Autor: Hassan MM; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Han Y; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA., Byun J; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA., Hatia RI; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Long E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Choi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Cleary SP; Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA., Lok AS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Bracci P; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., Permuth JB; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida, USA.; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Bucur R; Princess Margaret Cancer Center and Toronto General Hospital, University Health Network, Toronto, Ontario, Canada., Yuan JM; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Singal AG; Division of Digestive and Liver Diseases, The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Jalal PK; Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA., Ghobrial RM; J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, Texas, USA., Santella RM; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York City, New York, USA., Kono Y; Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California, USA., Shah DP; Mays Cancer Center, The University of Texas Health Science Center San Antonio MD Anderson, San Antonio, Texas, USA., Nguyen MH; Division of Gastroenterology and Hepatology, Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California, USA., Liu G; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Parikh ND; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Kim R; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Wu HC; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York City, New York, USA., El-Serag H; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Chang P; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li Y; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chun YS; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gu J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hawk E; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huff C; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rashid A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Beretta L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Antwi SO; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA., Patt Y; Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA., Hwang LY; Department of Epidemiology, Human Genetics, and Environment Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Zhang K; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Schmidt MA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., White DL; Sections of Gastroenterology and Hepatology and Health Services Research, Baylor College of Medicine, Houston, Texas, USA., Goss JA; Division of Abdominal Transplantation, Michael E. DeBakey School of Medicine, Baylor College of Medicine, Houston, Texas, USA., Khaderi SA; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, USA., Marrero JA; Division of Digestive and Liver Diseases, The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Cigarroa FG; Transplant Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Shah PK; Mays Cancer Center, The University of Texas Health Science Center San Antonio MD Anderson, San Antonio, Texas, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Amos CI; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 Jul 01; Vol. 80 (1), pp. 87-101. Date of Electronic Publication: 2024 Feb 20.